Capital models that lag portfolio change quietly generate wrong SCR figures, misallocate capital, and mislead underwriting decisions, creating accumulating executive risk that most reinsurance CROs underestimate until a model validation or rating agency review exposes the gap.
2026-08-03
Read moreBoards that approve cross-border reinsurance programmes without demanding evidence of collateral enforceability are tolerating a risk they have not measured. The board's governance question is simple: can management prove the collateral will be there when we need it?
2026-08-03
Read moreCollateral friction in cross-border structures demands a coordinated leadership response—the CUO who controls placement, the CFO who manages capital cost, and the CRO who governs enforceability risk must act from a shared framework, not from separate departmental perspectives.
2026-08-03
Read moreCollateral friction in cross-border reinsurance does not just create recovery risk—it imposes a direct cost on profitable growth by inflating regulatory capital consumption, increasing the cost of retro capacity, and forcing the firm to allocate shareholder capital to fund the friction gap instead of funding underwriting expansion.
2026-08-03
Read moreCollateral friction cannot be managed until it is measured—and most reinsurers measure collateral in binary present-or-absent terms that obscure the probabilistic nature of cross-border recovery. Building a friction measurement and management process is the operating-model change that converts uncertainty into control.
2026-08-03
Read moreCollateral friction in cross-border reinsurance does not just create recovery risk—it imposes a direct cost on profitable growth by inflating regulatory capital consumption, increasing the cost of retro capacity, and forcing the firm to allocate shareholder capital to fund the friction gap instead of funding underwriting expansion.
2026-08-03
Read moreWhen a regulator or rating agency asks management to demonstrate control of counterparty credit concentration, the answer must be evidence, not assertion. Boards that cannot produce the evidence trail are governing a risk they cannot prove is governed.
2026-08-03
Read moreCounterparty credit concentration sits at the intersection of four functions, owned by none of them. When ownership is fragmented, concentration accumulates silently until a downgrade or default forces the question of who was supposed to be watching.
2026-08-03
Read moreCounterparty credit concentration silently erodes underwriting margins, inflates regulatory capital charges, and forces bad-debt provisioning that no single P&L line captures—until a default event makes the cumulative damage visible in a single quarter.
2026-08-03
Read moreWhen concentration limits exist on paper but are not embedded in the placement workflow, the control framework is documenting risk rather than governing it. Reinsurers need controls that operate at the speed of decision, not the speed of reporting.
2026-08-03
Read moreCounterparty credit concentration in reinsurance is not a back-office clerical matter—it is a front-line earnings exposure that silently erodes surplus, distorts SCR calculations, and blindsides CUOs during renewal. Reinsurers that treat this as operational hygiene will discover its true financial magnitude only when a single retrocessionaire default cascades across multiple treaties.
2026-08-03
Read moreEvery board that tolerates cross-line subsidies should be able to answer one question: how much capital are we willing to deploy to lines that cannot stand on their own? The risk-appetite test for cross-line subsidies is the board's framework for drawing that line.
2026-08-03
Read moreWhen the executive committee cannot distinguish between lines that create value and lines that consume it, every strategic decision - capital allocation, talent deployment, market entry, exit - is compromised. Cross-line subsidies demand answers to questions most executive committees are not asking.
2026-08-03
Read moreCross-line subsidies don't just transfer profits from strong lines to weak ones - they amplify earnings volatility and destabilize the entire portfolio. When the subsidizing lines hit a downturn, the true financial exposure is revealed all at once.
2026-08-03
Read moreThe difference between catching a cross-line subsidy in its first year and discovering it in its fifth is the difference between a manageable remediation and a portfolio crisis. An early-warning system is the operating control that makes that difference.
2026-08-03
Read moreWhen profitable lines silently subsidize unprofitable ones, portfolio-level returns look healthy while structural weaknesses fester beneath the surface. Cross-line subsidies are the most dangerous risk in reinsurance because they are invisible to conventional reporting.
2026-08-03
Read moreDividend plans built on optimistic recoveries create hidden liabilities, overstate surplus, and force emergency capital actions when recovery shortfalls crystallize. Leaders who diagnose this risk can realign dividend policy with balance-sheet reality.
2026-08-03
Read moreDividend plans built on optimistic recoveries are not a reserving-department concern. They are a portfolio-level strategic risk that affects capital allocation, competitive positioning, and stakeholder confidence, requiring CEO and CUO leadership to govern the assumptions before they become financial surprises.
2026-08-03
Read more
